Previous Article | Next Article 
Journal of Virology, December 2000, p. 11278-11285, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
DNA-Dependent Protein Kinase Is Not Required for
Efficient Lentivirus Integration
Veerle
Baekelandt,1
Anje
Claeys,2
Peter
Cherepanov,2
Erik
De
Clercq,2
Bart
De
Strooper,3,4
Bart
Nuttin,1 and
Zeger
Debyser2,*
Rega Institute for Medical
Research,2 Laboratory for Experimental
Neurosurgery and Neuroanatomy,1
Center for Human Genetics,3 and
Flanders Interuniversitary Institute for
Biotechnology,4 Katholieke Universiteit
Leuven, Leuven, Belgium
Received 26 April 2000/Accepted 26 July 2000
 |
ABSTRACT |
How DNA is repaired after retrovirus integration is not well
understood. DNA-dependent protein kinase (DNA-PK) is known to play a
central role in the repair of double-stranded DNA breaks. Recently, a
role for DNA-PK in retroviral DNA integration has been proposed (R. Daniel, R. A. Katz, and A. M. Skalka, Science 284:644-647,
1999). Reduced transduction efficiency and increased cell death by
apoptosis were observed upon retrovirus infection of cultured
scid cells. We have used a human immunodeficiency virus
(HIV) type 1 (HIV-1)-derived lentivirus vector system to further
investigate the role of DNA-PK during integration. We measured
lentivirus transduction of scid mouse embryonic fibroblasts (MEF) and xrs-5 or xrs-6 cells. These cells are deficient in the catalytic subunit of DNA-PK and in Ku, the DNA-binding subunit of
DNA-PK, respectively. At low vector titers, efficient and stable lentivirus transduction was obtained, excluding an essential role for
DNA-PK in lentivirus integration. Likewise, the efficiency of
transduction of HIV-derived vectors in scid mouse brain was as efficient as that in control mice, without evidence of apoptosis. We
observed increased cell death in scid MEF and xrs-5 or
xrs-6 cells, but only after transduction with high vector titers
(multiplicity of infection [MOI], >1 transducing unit [TU]/cell)
and subsequent passage of the transduced cells. At an MOI of <1
TU/cell, however, transduction efficiency was even higher in
DNA-PK-deficient cells than in control cells. Taken together, the data
suggest a protective role of DNA-PK against cellular toxicity induced
by high levels of retrovirus integrase or integration. Another
candidate cellular enzyme that has been claimed to play an important
role during retrovirus integration is poly(ADP-ribose) polymerase
(PARP). However, no inhibition of lentivirus vector-mediated
transduction or HIV-1 replication by 3-methoxybenzamide, a known PARP
inhibitor, was observed. In conclusion, DNA-PK and PARP are not
essential for lentivirus integration.
 |
INTRODUCTION |
Integration is an essential step in
the retrovirus replication cycle (8). The viral integrase
catalyzes both the 3' processing of the viral DNA ends and the
insertion of the viral DNA into the host chromosome. This insertion is
mediated by a coordinated nucleophilic attack by the hydroxyl groups of
both processed ends on both strands of the phosphodiester backbone of
the host DNA, followed by the ligation of the viral 3' ends to the
cellular DNA. The result is a gapped intermediate in which the viral 5' ends are not joined to the host DNA. Resolution of the integration intermediate leads to the chromosomal insertion of the proviral DNA
trimmed of both terminal dinucleotides and flanked by a duplicated host
DNA fragment. The size of the DNA duplication is virus specific. For
human immunodeficiency virus (HIV), a 5-bp duplication is formed.
Cellular DNA repair mechanisms are generally believed to fill in and
ligate the remaining single-stranded DNA gaps, although the underlying
mechanisms have not been characterized. Alternatively, viral enzymes
may be involved. Reverse transcriptase could fill in the gaps and,
after removal of the two overhanging nucleotides at the 5' end of the
viral DNA, the DNA splicing activity of integrase could ligate the
viral DNA to the target DNA (11, 35). A report that
integrase would also have the required DNA polymerase activity awaits
independent confirmation (2).
In eukaryotic cells, nonhomologous end joining represents the major
mechanism for the repair of double-stranded DNA (dsDNA) breaks
(26, 30). In eukaryotes, dsDNA breaks occur during V(D)J
recombination and during meiotic recombination and are also generated
by ionizing radiation. Nonhomologous end joining is mediated by
DNA-dependent protein kinase (DNA-PK), a kinase activated by dsDNA ends
(19, 24). DNA-PK is composed of a 450-kDa catalytic subunit
(DNA-PKCS) and the heterodimeric protein Ku, composed of
70- and 86-kDa subunits. Ku is the DNA-binding component of DNA-PK
required for the activation of the catalytic subunit. Ku binds strongly
to dsDNA ends and, at least in vitro, to gapped and nicked DNA
molecules as well (5, 20). Mice with severe combined
immunodeficiency (scid) have a DNA-PKCS
truncation mutation in both alleles (6, 14). This
scid mutation affects V(D)J rearrangement and double-strand
break repair, resulting in the lack of mature B and T lymphocytes in
scid mice (7). Primary cells derived from
scid mice are deficient in DNA-PK activity (27,
30). Chinese hamster ovary (CHO) cell lines deficient in Ku86
(xrs-5 and xrs-6) are also available (15, 25). Like scid cells, these mutant cell lines are highly sensitive to irradiation.
A role for nonhomologous end joining in general and DNA-PK in
particular in repairing both DNA breaks generated by retrovirus integration is certainly conceivable. Recently, DNA-PK was claimed to
be required for retrovirus integration (13). It was shown that integration efficiency was reduced in DNA-PK-deficient murine scid cells and that high-titered virus stocks induced
apoptosis in these cells.
Another candidate cellular enzyme that could play an important role
during retrovirus integration is poly(ADP-ribose) polymerase (PARP)
(22). This nuclear enzyme (EC 2.4.2.30) is a zinc finger protein of 113 kDa that can bind to both single-stranded DNA and dsDNA
breaks and that is believed to participate in a number of cellular
processes involving DNA break formation and rejoining (9,
16). PARP activity is stimulated by a variety of DNA-damaging agents, including ionizing irradiation, alkylating agents, and oxygen
radicals. PARP catalyzes the attachment of polymers of the ADP-ribose
moiety of its substrate, NAD, to various proteins, including itself.
After automodification, the protein dissociates from the DNA, providing
access to other components of the DNA repair system (36).
PARP is believed to protect the integrity of the genome by preventing
accidental homologous DNA recombination (9). Excessive
stimulation of PARP may deplete NAD and lead to cell death
(33). Selective PARP inhibitors, such as 3-methoxybenzamide (3-MB) are known (34). Infection of mammalian cells by
recombinant retrovirus vectors is inhibited by inhibition of PARP
activity (22), suggesting a role during retrovirus integration.
In the context of the establishment of a cellular integration system
(10), we have investigated the possible requirements of
DNA-PK and PARP for efficient lentivirus integration. To our surprise
and in contrast to published reports, we have found no evidence that
these enzymes are essential for integration at multiplicities of
infection (MOI) below 1 transducing unit (TU)/cell.
 |
MATERIALS AND METHODS |
Cell cultures.
HeLa, CHO-K1, xrs-5, and xrs-6 cells were
obtained from the American Type Culture Collection. By limiting
dilution, individual clones of the Ku-deficient CHO-K1-derived cell
lines xrs-5 and xrs-6 (xrs-5/2 and xrs-6/1) in which the absence of the
Ku protein was verified by Western blotting were selected (data not
shown). Human embryonic kidney 293T cells expressing simian virus 40 (SV40) large T antigen, were obtained from O. Danos (Evry, France).
Wild-type (WT) mouse embryonary fibroblasts (MEF) were obtained from
embryos of C57Black/6J and 129/OLA parents; scid MEF were
obtained from CB-17/scid × scid mice. Cells
were grown in Dulbecco's modified Eagle's medium (DMEM) containing
Glutamax-I and supplemented with 10% fetal calf serum (FCS) (Harlan
Sera-Lab LTD) and 20 µg of gentamicin (Gibco BRL) per ml at 37°C in
a 5% CO2 humidified atmosphere. 293T cells were
transfected using polyethyleneimine (PEI) (average molecular weight,
25,000; Sigma-Aldrich, Bornem, Belgium) (1); MEF cells were
transfected using Lipofectamine (Gibco BRL). The continuous cell lines
WT MEF-T and scid MEF-T were obtained by transfecting WT and
scid MEF at 50 to 70% confluence with pMSSVLT, encoding
SV40 large T antigen. At 48 h after transfection, 500 µg of
Geneticin (G418) per ml was added to the culture medium to select
stable transfectants. The number of viable cells was determined by
trypan blue exclusion. Anti-HIV activity and cytotoxicity measurements
for MT-4 cells were based on viability measurements using a
tetrazolium-based colorimetric method (32).
Lentivirus vector production.
HIV type 1 (HIV-1)-derived
vector particles, pseudotyped with the envelope of vesicular stomatitis
virus, were produced by transfecting 293T cells with a packaging
plasmid encoding viral Gag, Pol, and accessory proteins (pCMV
R8.2),
a plasmid encoding the envelope of vesicular stomatitis virus (pMDG),
and a plasmid carrying a reporter gene flanked by two long terminal
repeats (pHR'-CMVLacZ) (31). A second-generation attenuated
packaging plasmid, pCMV
R8.91, which lacks the vif,
vpr, vpu, and nef genes (39), was used as well. All plasmids were kindly provided by O. Danos and D. Trono (Geneva, Switzerland).
For transfection of a 10-cm dish of 293T cells, 20 µg of vector
plasmid, 10 µg of packaging construct, and 5 µg of envelope plasmid
were mixed in 700 µl of 150 mM NaCl. PEI solution (1.57 mM PEI in 150 mM NaCl) (700 µl) was added slowly. The mixture was incubated at room
temperature for 15 min and then added dropwise to 293T cells in DMEM
containing 1% FCS. On the next morning, the medium was replaced with
DMEM containing 10% FCS. Supernatants were collected from day 2 until
day 5 posttransfection. The vector particles in the supernatants were
sedimented by ultracentrifugation in a swinging-bucket rotor (SW27;
Beckman, Palo Alto, Calif.) at 25,000 rpm for 2 h at 4°C.
Pellets were redissolved in 300 µl of phosphate-buffered saline
(PBS), resulting in a 100-fold concentration. p24 antigen content was
determined using an HIV-1 p24 core profile enzyme-linked immunosorbent
assay (DuPont, Dreieich, Germany), and viral titers were determined by
end-point dilution and
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal)
staining of transduced cells. p24 content was used to normalize the
different vector batches.
For transduction experiments, cells were seeded at 10,000/well in
96-well plates. After 24 h, the medium was replaced with DMEM
containing 1% FCS, and the cells were infected with different amounts
of vector supplemented with 2 µg of Polybrene per ml. On the next
morning, the supernatant was replaced with fresh medium containing 10%
FCS.
-Galactosidase reporter gene activity was measured 3 days after
transduction. Cells were washed with PBS, fixed with 2%
formaldehyde-0.2% glutaraldehyde in PBS, and stained with freshly
prepared X-Gal substrate (5 mM potassium ferrocyanide, 5 mM potassium
ferricyanide, 2 mM MgCl2, and 400 µg of X-gal per ml
[Biotech Trade & Service GmbH, St. Leon-Rot, Germany] in PBS) at
37°C overnight. Individual blue cells were counted microscopically. Alternatively, total
-galactosidase activity in the cell lysate was
determined. Medium was removed by gentle aspiration, and the monolayers
were washed with PBS. Cells were lysed in 25 µl of 0.5% Nonidet
P-40. Five microliters of the extract was used to determine total
protein content according to the Bradford method (Bio-Rad, Hercules,
Calif.). The remaining volume was used to measure the conversion of
o-nitrophenyl-
-D-galactopyranoside (Sigma-Aldrich) in a colorimetric assay as described previously (3). Results were normalized to the total protein
concentration. In experiments evaluating titer-dependent cellular
toxicity, this normalization of reporter gene activity was not done.
In vivo analysis of lentivirus vector transduction.
Adult
CB-17/scid × scid and C57Black/6 mice of
both sexes were used. All surgical procedures were performed under
chloral hydrate anesthesia (400 mg/kg of body weight intraperitoneally) using aseptic procedures. The mice were placed in a stereotactic head
frame (Narishige); after midline incision of the skin, one or two small
holes were drilled in the skull in the appropriate location (AP 0.5, LAT 2.0, and DV 3.0, using bregma as a reference point
[21]). Two microliters of highly concentrated vector
(108 pg of p24/ml) supplemented with 4 µg of Polybrene
per ml was injected at a rate of 0.5 µl/min with a 30-gauge needle
connected by microdialysis tubing to a 25-µl Hamilton syringe in a
microinjection pump (CMA/microdialysis AB, Stockholm, Sweden). The
needle was raised slowly 0.25 mm in the dorsal direction every 60 s during the 4-min injection. After the injection, the needle was left in place for an additional 4 min before being withdrawn slowly from the
brain (protocol adapted from that in reference 18).
To assess lentivirus transduction, the mice were deeply anesthetized
with pentobarbital and perfused transcardially with saline followed by
ice-cold 4% paraformaldehyde in PBS for 15 min. The brain was removed
from the skull and postfixed overnight in the same fixing solution.
Coronal brain sections (50 µm thick) were cut with a vibratome and
stored at 4°C in PBS containing 0.1% sodium azide. The sections were
first screened for green fluorescent protein (GFP) expression with an
inverted fluorescence microscope. More sensitive detection was obtained
by immunohistochemical analysis with a polyclonal antibody against GFP
(Clontech, Palo Alto, Calif.). The sections were treated with 3%
hydrogen peroxide and preincubated in 5% normal swine serum-0.1%
Triton X-100 in PBS. The anti-GFP primary antibody (1:1,000) in 5%
normal swine serum-0.1% Triton X-100 was added and incubated
overnight at room temperature. The sections were then incubated with
biotinylated swine anti-rabbit secondary antibody, followed by Strept
ABC-HRP complex (Dako, Glostrup, Denmark). Detection was accomplished
with diaminobenzidine and H2O2 as a substrate.
Astrocytes and neurons were identified using a polyclonal antibody
against glial fibrillary acidic protein (GFAP; Dako) and a monoclonal
antibody against NeuN (Chemicon, Temecula, Calif.), respectively. TUNEL
(terminal deoxynucleotidyltransferase [TdT]-mediated dUTP-biotin nick
end labeling) staining was performed according to a protocol adapted
from that of Young et al. (38). Briefly, sections were
pretreated with 1% H2O2 in methanol and then
incubated in 0.1% sodium citrate buffer containing 0.1% Triton X-100
on ice for 2 min. The labeling reaction with TdT in the presence of
biotin-16-dUTP was performed for 4 h at 37°C. Next, the
sections were incubated with Strept ABC-HRP complex and stained with
diaminobenzidine and H2O2. Sections treated
with DNase I for 30 min at 37°C prior to TdT incubation were used as
a positive control.
Quantitative analysis of GFP expression was carried out by means of a
Bioquant image analyzing system (R&M Biometrics, Nashville, Tenn.). For
each animal, serial sections (minimum of six) were analyzed over a
distance of 2 mm centered around the injection site. For each section,
the relative density and the number of pixels above a threshold of
intensity were measured in the area of the striatum that was positive
for GFP expression.
 |
RESULTS |
Efficient transduction of scid cells by lentivirus
vectors.
The role of DNA-PK during lentivirus integration was
investigated using amphotropic HIV-1-derived lentivirus vectors
(31, 39) that encode
-galactosidase as a marker protein.
The vectors retrotranscribe and integrate their genomes into the host
chromosome much like the parental virus, but they cannot replicate due
to the lack of viral coding sequences. This model system can thus be
used to study the requirements of lentivirus integration. It was
possible to transduce MEF using lentivirus vectors, although the
efficiency of transduction in these cells was lower than that in
established cell lines, such as 293T, HeLa, or CHO. To verify whether
DNA-PK was required for integration, scid and WT MEF cells were transduced at low MOI (<0.1 TU/cell) to prevent infection by more
than one particle per cell. MEF derived from scid mice were
as efficiently transduced as MEF derived from WT mice (Fig. 1). Both with WT and with attenuated
vectors (the latter lacking the four HIV accessory genes),
scid MEF were transduced at least as efficiently as WT MEF.
Similar results were obtained for continuous cell lines (WT MEF-T and
scid MEF-T) derived from MEF after transformation with SV40
T antigen. Since the transduction efficiency in these cell lines was
reproducibly higher than that in primary cells, MEF-T were used for
further experiments. Lentivirus transduction of cells at the low titers
used in these experiments did not induce cell death. To exclude the
possibility that the need for DNA-PK-mediated DNA repair is apparent
only in cells undergoing mitosis, we passaged the transduced cells
prior to staining. After passage, the reporter gene activity remained
equally high in WT MEF-T and scid MEF-T (data not shown).


View larger version (163K):
[in this window]
[in a new window]
|
FIG. 1.
Lentivirus transduction efficiency in scid
cells. Different amounts of a second-generation HIV-1-derived
lentivirus vector (devoid of Vpr, Nef, Vif, and Vpu) encoding
-galactosidase were used to transduce subconfluent WT and
scid MEF. At confluence, WT (A) and scid (B) MEF
were stained with X-Gal, and positive WT ( ) or scid ( )
MEF were counted microscopically (C). Means and standard deviations of
duplicate experiments are shown.
|
|
Efficient integration of lentivirus vectors in Ku-deficient
cells.
In a second set of experiments, we verified the role of Ku,
the DNA-binding component of DNA-PK. The CHO-K1-derived cell lines xrs-5 and xrs-6 are deficient in Ku86 protein. The absence of Ku
protein was verified by Western blotting (data not shown). The relative
efficiency of lentivirus vector transduction in these cell lines was
compared with that in the parental CHO-K1 cell line (Fig.
2). The average transduction efficiencies
were 70% in xrs-5 cells and 152% in xrs-6 cells relative to the
transduction efficiency in CHO-K1 cells (Fig. 2A). Transduction was not
accompanied by cell death (Fig. 2B). After passage of the transduced
cells, the
-galactosidase-positive colonies were counted. Results
similar to those obtained in transient transduction experiments were
obtained (Fig. 2C). In mammalian cells, there is evidence that Ku plays a role in transcriptional regulation (23, 28, 29). This idea
raised the possibility that in the absence of Ku, reduced transcription
of integrated provirus could lead to an underestimation of apparent
transduction efficiency when total reporter gene activity is measured.
We quantified the total
-galactosidase activity of the cell lysate
photometrically. Again, at MOI of 0.04 TU/cell, reporter gene activity
was about 2-fold lower in xrs-5 cells but 1.5-fold higher in xrs-6
cells relative to the activity in the maternal cell line (data not
shown). No significant reduction in reporter gene activity could thus
be demonstrated in the absence of Ku.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
Lentivirus transduction efficiency in Ku-deficient cell
lines. Subconfluent CHO-K1 ( ), xrs-5/2 ( ), and xrs-6/1 ( )
cells were transduced with different amounts of a first-generation
lentivirus vector and stained after 3 days. The number of
-galactosidase-positive cells (A) and the cell count (B) were
determined microscopically. After passage (1/5) of the transduced
CHO-K1 ( ), xrs-5/2 ( ), and xrs-6/1 ( ) cells,
-galactosidase-positive colonies ( 10 blue cells) were counted at
confluence (C). Means and standard deviations of duplicate experiments
are shown.
|
|
Efficient lentivirus transduction of scid mouse
brain.
We have been studying the potential of HIV-1-derived
lentivirus vectors for gene transfer into the murine brain as a step toward future gene therapy of neurodegenerative diseases (4, 31). In this context, we used scid mice in parallel
with immunocompetent C57Black/6 (C57BL) mice to investigate potential
immunological reactions to vector or transgene. Highly concentrated
vector (2 × 105 pg of p24) encoding GFP was injected
stereotactically into the striatum of adult mice, and the expression of
the transgene was evaluated by immunohistochemical analysis. The levels
of GFP 2 and 11 weeks after injection were as high in scid
mice as in control C57BL mice (Fig. 3).
GFP expression was evident in both neurons and glial cells (data not
shown). Thus, although deficient for DNA-PK, brain cells of
scid mice were efficiently and stably transduced by
HIV-1-derived lentivirus vectors. Daniel et al. attributed the lower
retrovirus integration efficiency in scid cells to increased cell death by apoptosis (13). Nissl staining of brain
sections of scid and C57BL mice did not reveal extensive
cell loss in the transduced area. We also performed TUNEL staining to
visualize apoptotic cells after lentivirus vector-mediated gene
transfer (Fig. 4). Since reactive
apoptosis is likely to occur as an early event after transduction, we
included a time point 2 days after transduction. GFP expression was
indeed evident after 2 days, but TUNEL staining was negative for brain
slices from both scid and C57BL mice at all time points
analyzed (Fig. 4). In conclusion, the results obtained with our in vivo
model argue against an essential role for DNA-PK during lentivirus
integration.

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 3.
Efficient lentivirus transduction in scid
mouse brain. (Top) Expression of the GFP transgene in the striatum of
C57BL and scid mice 2 weeks after transduction with the same
batch of lentivirus vectors. Serial sections with an interval of 250 µm showed equal transduction efficiency in both mouse strains.
(Bottom) Quantification of GFP expression in serial sections over a
distance of 2 mm around the injection site in the striatum of
scid and C57BL mice 11 weeks after lentivirus vector
transduction. The y axis indicates the area of positive GFP
expression. Although there was some interindividual variation in
transgene expression, no significant difference between scid
and C57BL mice was observed.
|
|

View larger version (129K):
[in this window]
[in a new window]
|
FIG. 4.
No evidence for increased apoptosis after lentivirus
transduction in scid mouse brain. (A and D) GFP expression
around the needle track in the striatum of scid mice 2 days
(A) and 2 weeks (D) after lentivirus transduction. (B and E) TUNEL
staining of adjacent sections shows no apoptotic cells in the area of
the striatum positive for GFP expression 2 days (B) and 2 weeks (E)
after lentivirus transduction. (C) DNase treatment of a section like
that in the positive control results in numerous labeled nuclei. Scale
bar, 100 µm.
|
|
No inhibition of lentivirus integration by inhibitors of PARP
activity.
We extended our study to a second candidate repair
enzyme, PARP. This enzyme has been thought to play an essential role
during retrovirus integration, based on the inhibition of retrovirus transduction by competitive inhibitors of PARP (22). 3-MB is an inhibitor of PARP with a reported 50% inhibitory concentration (IC50) for lentivirus transduction or viral replication of
approximately 0.8 mM, whereas 4-methoxybenzamide (4-MB) is an inactive
analogue. We performed lentivirus transduction experiments with CHO-K1
and xrs-5 or xrs-6 cells in the presence of various concentrations of
3-MB or 4-MB. The cells were preincubated with the inhibitors for
24 h prior to infection. Lentivirus transduction was assessed by
measuring
-galactosidase activity in fixed cells or in a cell lysate. At nontoxic concentrations, 3-MB did not interfere with lentivirus transduction (Table 1). We
also evaluated the effects of 3-MB and 4-MB against HIV-1 (strain
IIIB) replication in MT-4 cell cultures. Again, no
inhibition was seen at the concentrations tested (up to 5 mM).
Cellular toxicity induced in DNA-PK-deficient cells by high titers
of lentivirus vectors.
In all of our experiments so far, low MOI
were used to investigate the requirement of DNA-PK for lentivirus
integration. Recently, Daniel et al. proposed an essential role for
DNA-PK during retrovirus integration based on results obtained with
high viral titers (13). To examine the effect of high
lentivirus vector titers, additional cell culture experiments were
performed. We compared the lentivirus transduction of WT versus
scid MEF-T (Fig. 5) and of
CHO-K1 versus xrs-5 or xrs-6 cells (Fig.
6). Transduction of subconfluent cells was performed at different MOI.
-galactosidase activity was measured 3 days after transduction and at confluence after passage of the transduced cells.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 5.
Titer- and passage-dependent cellular toxicity after
lentivirus transduction of scid cells. Subconfluent WT ( )
or scid ( ) MEF-T were transduced in duplicate with
different amounts of a second-generation lentivirus vector devoid of
Vpr, Nef, Vif, and Vpu. Half of the cells were analyzed at confluence
(A and B), and half of the cells were passaged (1/5) and analyzed at
confluence (C and D). -Galactosidase activity (OD, optical density)
was measured in the cell lysate (A and C), and the cell count was
determined by trypan blue dye exclusion (B and D). Reporter gene
activity was not normalized for differential cell growth. Means and
standard deviations of duplicate experiments are shown.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 6.
Titer- and passage-dependent cellular toxicity after
lentivirus transduction of Ku-deficient cells. Subconfluent CHO-K1
( ), xrs-5/2 ( ), and xrs-6/1 ( ) cells were transduced in
duplicate with different amounts of a second-generation lentivirus
vector. Half of the cells were analyzed at confluence (A and B), and
half of the cells were passaged (1/5) and analyzed at confluence (C and
D). -Galactosidase activity (OD, optical density) was measured in
the cell lysate (A and C), and the cell count was determined by trypan
blue dye exclusion (B and D). Reporter gene activity was not normalized
for differential cell growth. Means and standard deviations of
duplicate experiments are shown.
|
|
The reporter gene activity was always higher in scid than in
WT MEF-T, even when higher MOI were used (Fig. 5A). At MOI of 6 TU/cell, mild toxicity in scid but not in WT MEF-T was
evidenced by small reductions in cell count (Fig. 5B) and in total
protein content (data not shown). Remarkably, scid MEF-T
transduced with the highest titers of vector displayed massive cell
death after passage (Fig. 5D), resulting in reduced reporter gene
activity (Fig. 5C). At low MOI, this toxicity was not observed.
Analogous results were obtained with the Ku-deficient cell lines (Fig.
6). Lentivirus vector-mediated transduction efficiency for xrs-5 or xrs-6 cells was not below that of the parental CHO-K1 cells (Fig. 6A).
At high vector titers, some cellular toxicity was observed for
Ku-deficient cell lines (Fig. 6B). However, after subcultivation, cell
death was pronounced in the Ku-deficient cells transduced with high
titers but not in the CHO-K1 cells (Fig. 6D). The cell death resulted
in a reduction in total
-galactosidase activity in xrs-5 or xrs-6
cells (Fig. 6C).
 |
DISCUSSION |
It remains unresolved to what extent the retroviral enzymes
reverse transcriptase (gap filling) and integrase (DNA splicing [11]) or the eukaryotic host proteins, such as DNA-PK
and PARP, contribute to the DNA repair of the single-stranded DNA gaps
that remain after retrovirus integration. A role for PARP as a nick sensor during retrovirus integration has been postulated
(22). In our experimental design, the PARP inhibitor 3-MB
was not capable of interfering with lentivirus vector transduction or
HIV-1 replication, arguing against an important role for this enzyme
during lentivirus integration.
To investigate the role of DNA-PK during retrovirus integration, we
analyzed the transduction efficiency of HIV-1-derived lentivirus
vectors in scid and xrs-5 or xrs-6 cells, which are deficient in the DNA-PK pathway. We previously showed that a vector carrying the inactivating D64V mutation in the integrase gene gave rise
to only 5% the transduced cells obtained with the WT vector
(10). After passage of transduced cells, this
pseudotransduction level even fell below 1%. Since transduction by HIV
vectors is thus largely dependent on the integration step, the
efficiency of transduction can be used to evaluate cofactors essential
for integration. We reasoned that the use of low vector titers would increase the likelihood that the requirement for a potential host factor would become apparent. Since lentivirus transduction was as
efficient in scid, xrs-5, or xrs-6 cells as in WT cells, an essential role for DNA-PK in integration was ruled out. These results
were confirmed with an in vivo model. We have been investigating the
potential of lentivirus vectors for in vivo gene transfer after
stereotactic injection into the brain (4). scid
mice were used to control for the immunological response to the vector or transgene. In this in vivo model, the transduction of neurons and
glial cells was at least as efficient in scid mice as in
C57BL mice.
Our results with cell cultures and with the in vivo mouse model do
exclude an essential role for DNA-PK during lentivirus integration.
During the course of our experimental work, however, a study by Daniel
et al. was published, wherein an essential role for DNA-PK during
retrovirus integration was claimed (13). The claim was based
on the observation that retrovirus transduction was reduced in
scid cells and accompanied by cell death due to apoptosis.
Intriguingly, this effect was reported to occur at viral MOI of
1
TU/cell. Our cell culture data were obtained at low MOI. In the in vivo
model, the actual MOI is difficult to estimate. It is determined by the
limited amount of virus (at maximal titer) that one can inject into the
brain and the area of diffusion. One can assume that a concentration
gradient exists, with high MOI around the injection site, where
mechanical damage around the needle track may mask apoptosis.
Therefore, we repeated lentivirus transduction experiments at high MOI
and using a colorimetric detection method. We analyzed the efficiency
of both transient transduction of subconfluent cells and stable
transduction after subcultivation. Daniel et al. selected for
neomycin-resistant colonies after retrovirus transduction
(13). In our experiments, different plating efficiencies for
DNA-PK-deficient cell lines compromised this approach. Moreover, since
Ku is known to be involved in transcriptional regulation, expression
levels rather than transduction levels can influence test results. At
an MOI of 6 TU/cell, toxicity was observed in scid and xrs-5
or xrs-6 cells 3 days after transduction. Even at this MOI, the
reporter gene activity remained higher in the DNA-PK-deficient cells,
ruling out interference with the integration step. Passage of the
transduced cells, however, was associated with pronounced cell death in
the DNA-PK-deficient cells. Here, overall reporter gene activity
dropped, more by reduction of cell number than by reduction of gene
expression per cell. In agreement with the published data, extensive
retrovirus transduction in DNA-PK-deficient cells is apparently
associated with cell death, especially when cells are forced to divide.
The absence of apoptosis after in vivo transduction of neuronal cells
might be due to the fact that they are postmitotic cells.
The results of Daniel et al. were based on transduction with both
retrovirus and HIV-derived lentivirus vectors (13). Since our experiments were carried out only with HIV-derived lentivirus vectors, our conclusions are confined to lentivirus integration. We
used an attenuated HIV-derived vector for experiments at high MOI to
avoid potential cellular toxicity due to the presence of Vpr in the
virus particle, as has been described elsewhere (37).
The DNA-binding component of DNA-PK was recently shown to potentiate
retrotransposition of the Ty element of Saccharomyces cerevisiae in a galactose-inducible Ty1 system (17).
However, the same authors reported that the level of endogenous Ty1
retrotransposition was almost twofold higher in the absence of Ku, an
effect that they attributed to the transcriptional induction of genes
responsive to DNA damage, such as Ty1 genes, in the abence of Ku.
However, on the basis of our results with lentivirus transduction, it
may be argued that the requirement of Ku for retrotransposition is linked to the overexpression of the Ty1 element. Since Ty1
retrotransposition was scored by selection of transduced colonies, the
distinction between lack of integration or integration-induced cell
death in the absence of Ku was not made. We hypothesize that high
levels of retrotransposition induce cell death in the absence of Ku.
Our data do not exclude the possibility that an alternative cellular
pathway can substitute for DNA-PK during lentivirus integration. Nevertheless, our data argue against an essential role for this enzyme
and question its suitability as an antiviral target. Scepticism toward
a universal role for DNA-PK in retrovirus integration was already
expressed by Coffin and Rosenberg (12). It was pointed out
that primary B cells from scid mice can be immortalized
efficiently by infection with a retrovirus. Coffin and Rosenberg
(12) suggested that, instead, DNA-PK might protect the cell
from a side effect of integration. Although we were able to obtain data
analogous to those of Daniel et al. (13), namely, cell death
induced by lentivirus transduction of DNA-PK-deficient cells, we
observed this effect only after transduction with excess vector and
especially when the transduced cells were forced to divide. Since
transduction was affected less than cell survival, the lack of DNA-PK
apparently does not prevent integration as such. Moreover, at low viral
titers, lentivirus transduction was apparently more efficient in most DNA-PK-deficient cells. Together, our data tend to support the notion
of a protective role for DNA-PK during excessive retrovirus integration. In this context, DNA-PK may play a physiological role in
protection against superinfection. More research is required to
determine exactly what triggers cell death after excessive lentivirus
infection of DNA-PK-deficient cells and what protective role DNA-PK
plays in this process.
In conclusion, no evidence was found that DNA-PK or PARP is essential
for lentivirus integration when low virus titers are used. Another
cellular or a virus-mediated gap repair mechanism may be involved.
 |
ACKNOWLEDGMENTS |
Veerle Baekelandt and Anje Claeys contributed equally to this work.
We thank K. Craessaerts, K. Eggermont, and M. Michiels for excellent
technical assistance and the laboratory of F. Vandesande (Katholieke
Universiteit Leuven [KUL]) for use of the photographic and image
analysis equipment. We are grateful to M. Witvrouw (KUL) for anti-HIV
testing. The HIV-1-derived lentivirus vector system was a kind gift
from O. Danos (Evry, France) and D. Trono (University of Geneva). We
thank A. M. Skalka, R. Katz, and R. Daniel (Fox Chase Cancer
Center, Philadelphia, Pa.) for helpful discussions.
V.B. and Z.D. are postdoctoral fellows of the Flemish Fund for
Scientific Research (FWO). This work was funded by IDO grant 98/006
from the Katholieke Universiteit Leuven Research Council and the STWW
Program of the Flemish Institute Supporting Scientific-Technological Research in Industry (IWT).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Rega Institute
for Medical Research, Minderbroedersstr. 10, B-3000 Leuven, Belgium. Phone: 32 16 33 21 82. Fax: 32 16 33 21 31. E-mail:
zeger.debyser{at}uz.kuleuven.ac.be.
 |
REFERENCES |
| 1.
|
Abdallah, B.,
A. Hassan,
C. Benoist,
D. Goula,
J. P. Behr, and B. A. Demeneix.
1997.
A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine.
Hum. Gene Ther.
7:1947-1954.
|
| 2.
|
Acel, A.,
B. E. Udashkin,
M. A. Wainberg, and E. A. Faust.
1998.
Efficient gap repair catalyzed in vitro by an intrinsic DNA polymerase activity of human immunodeficiency virus type 1 integrase.
J. Virol.
72:2062-2071[Abstract/Free Full Text].
|
| 3.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl (ed.).
1987.
Current protocols in molecular biology.
John Wiley & Sons, Inc., New York, N.Y.
|
| 4.
| Baekelandt, V., B. De Strooper, B. Nuttin, and Z. Debyser. Gene therapeutic strategies for neurodegenerative
diseases. Curr. Opin. Mol. Ther., in press.
|
| 5.
|
Blier, P. R.,
A. J. Griffith,
J. Craft, and J. A. Hardin.
1993.
Binding of Ku protein to DNA. Measurement of affinity for ends and demonstration of binding to nicks.
J. Biol. Chem.
268:7594-7601[Abstract/Free Full Text].
|
| 6.
|
Blunt, T.,
N. J. Finnie,
G. E. Taccioli,
G. C. M. Smith,
J. Demengeot,
T. M. Gottlieb,
R. Mizuta,
A. J. Varghese,
F. W. Alt,
P. A. Jeggo, and S. P. Jackson.
1995.
Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation.
Cell
80:813-823[CrossRef][Medline].
|
| 7.
|
Bosma, G. C.,
R. P. Custer, and M. J. Bosma.
1983.
A severe combined immunodeficiency mutation in the mouse.
Nature
301:527-530[CrossRef][Medline].
|
| 8.
|
Brown, P. O.
1997.
Integration, p. 161-203.
In
J. Coffin, S. Hughes, and H. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 9.
|
Chatterjee, S.,
S. Berger, and N. Berger.
1999.
Poly(ADP-ribose)polymerase: a guardian of the genome that facilitates DNA repair by protecting against DNA recombination.
Mol. Cell. Biochem.
193:23-30[CrossRef][Medline].
|
| 10.
|
Cherepanov, P.,
W. Pluymers,
A. Claeys,
P. Proost,
E. De Clercq, and Z. Debyser.
2000.
High-level expression of active HIV-1 integrase from a synthetic gene in human cells.
FASEB J.
14:1389-1399[Abstract/Free Full Text].
|
| 11.
|
Chow, S. A.,
K. A. Vincent,
V. Ellison, and P. O. Brown.
1992.
Reversal of integration and DNA splicing mediated by integrase.
Science
255:723-726[Abstract/Free Full Text].
|
| 12.
|
Coffin, J. M., and N. Rosenberg.
1999.
Closing the joint.
Nature
399:413-414[CrossRef][Medline].
|
| 13.
|
Daniel, R.,
R. A. Katz, and A. M. Skalka.
1999.
A role for DNA-PK in retroviral DNA integration.
Science
284:644-647[Abstract/Free Full Text].
|
| 14.
|
Danska, J. S.,
D. P. Holland,
S. Mariathasan,
K. M. Williams, and C. J. Guidos.
1996.
Biochemical and genetic defects in the DNA-dependent protein kinase in murine scid lymphocytes.
Mol. Cell. Biol.
16:5507-5517[Abstract].
|
| 15.
|
Darroudi, F., and A. T. Natarajan.
1989.
Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs 5 and xrs 6. IV. Study of chromosomal aberrations and sister-chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II.
Mutat. Res.
212:137-148[CrossRef][Medline].
|
| 16.
|
de Murcia, G., and J. M. de Murcia.
1994.
Poly(ADP-ribose)polymerase: a molecular nick-sensor.
Trends Biochem. Sci.
19:172-176[CrossRef][Medline].
|
| 17.
|
Downs, J. A., and S. P. Jackson.
1999.
Involvement of DNA-end binding protein Ku in Ty element retrotransposition.
Mol. Cell. Biol.
19:6260-6268[Abstract/Free Full Text].
|
| 18.
|
Dull, T.,
R. Zufferey,
M. Kelly,
R. J. Mandel,
M. Nguyen,
D. Trono, and L. Naldini.
1998.
A third-generation lentivirus vector with a conditional packaging system.
J. Virol.
72:8463-8471[Abstract/Free Full Text].
|
| 19.
|
Dvir, A.,
S. R. Peterson,
M. W. Knuth,
H. Lu, and W. S. Dynan.
1992.
Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II.
Proc. Natl. Acad. Sci. USA
89:11920-11924[Abstract/Free Full Text].
|
| 20.
|
Falzon, M.,
J. W. Fewell, and E. L. Kuff.
1993.
EBP-80, a transcription factor closely resembling the human auto-antigen Ku, recognizes single- to double-strand transitions in DNA.
J. Biol. Chem.
268:10546-10552[Abstract/Free Full Text].
|
| 21.
|
Franklin, K. B. J., and G. Paxinos.
1997.
The mouse brain in stereotaxic coordinates.
Academic Press, Inc., San Diego, Calif.
|
| 22.
|
Gäken, J. A.,
M. Tavassoli,
S.-U. Gan,
S. Vallian,
I. Giddings,
D. C. Darling,
J. Galea-Lauri,
M. G. Thomas,
H. Abedi,
V. Schreiber,
J. Ménissier-de Murcia,
M. K. L. Collins,
S. Shall, and F. Farzaneh.
1996.
Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity.
J. Virol.
70:3992-4000[Abstract].
|
| 23.
|
Giffin, W.,
H. Torrance,
D. J. Rodda,
G. G. Préfontaine,
L. Pope, and R. J. G. Haché.
1996.
Sequence-specific DNA binding by Ku autoantigen and its effects on transcription.
Nature
380:265-268[CrossRef][Medline].
|
| 24.
|
Gottlieb, T. M., and S. P. Jackson.
1993.
The DNA-dependent protein kinase: requirement of DNA ends and association with Ku antigen.
Cell
72:131-142[CrossRef][Medline].
|
| 25.
|
Jeggo, P. A.
1990.
Studies on mammalian mutants defective in rejoining double-strand breaks in DNA.
Mutat. Res.
239:1-16[Medline].
|
| 26.
|
Jeggo, P. A.
1998.
DNA breakage and repair.
Adv. Genet.
38:185-219[Medline].
|
| 27.
|
Kirchgessner, C. U.,
C. K. Patil,
J. W. Evans,
C. A. Cuomo,
L. M. Fried,
T. Carter,
M. A. Oettinger,
J. M. Brown,
G. Iliakis,
R. Mehta, and M. Jackson.
1995.
DNA-dependent protein kinase (p350) as a candidate gene for murine SCID defect.
Science
267:1178-1183[Abstract/Free Full Text].
|
| 28.
|
Kuhn, A.,
T. M. Gottleib,
S. P. Jackson, and I. Grummt.
1995.
DNA-dependent protein kinase a potent inhibitor of transcription by RNA polymerase I.
Genes Dev.
9:193-203[Abstract/Free Full Text].
|
| 29.
|
Labhart, P.
1995.
DNA-dependent protein kinase specifically represses promoter-directed transcription initiation by RNA polymerase I.
Proc. Natl. Acad. Sci. USA
92:2934-2938[Abstract/Free Full Text].
|
| 30.
|
Lees-Miller, S. P.,
R. Godbout,
D. W. Chan,
M. Weinfeld,
R. S. Day,
G. M. Barron, and J. Allalunis-Turner.
1995.
Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line.
Science
267:1183-1185[Abstract/Free Full Text].
|
| 31.
|
Naldini, L.,
U. Blömer,
P. Gallay,
D. Ory,
R. Mulligan,
F. H. Gage,
I. M. Verma, and D. Trono.
1996.
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
Science
272:263-267[Abstract].
|
| 32.
|
Pauwels, R.,
J. Balzarini,
M. Baba,
R. Snoeck,
D. Schols,
P. Herdewijn,
J. Desmyter, and E. De Clercq.
1988.
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds.
J. Virol. Methods
20:309-321[CrossRef][Medline].
|
| 33.
|
Pieper, A. A.,
A. Verma,
J. Zhang, and S. H. Snyder.
1999.
Poly(ADP-ribose) polymerase, nitric oxide and cell death.
Trends Pharmacol. Sci.
20:171-181[CrossRef][Medline].
|
| 34.
|
Rankin, W. P.,
E. L. Jacobson,
R. C. Benjamin,
J. Moss, and M. K. Jacobson.
1989.
Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo.
J. Biol. Chem.
264:4312-4317[Abstract/Free Full Text].
|
| 35.
|
Roe, T.,
S. A. Chowand, and P. O. Brown.
1997.
3'-End processing and kinetics of 5'-end joining during retroviral integration in vivo.
J. Virol.
71:1334-1340[Abstract].
|
| 36.
|
Satoh, M. S., and T. Lindahl.
1992.
Role of poly(ADP-ribose) formation in DNA repair.
Nature (London)
356:356-358[CrossRef][Medline].
|
| 37.
|
Stewart, S. A.,
B. Poon,
J. Y. Song, and I. S. Y. Chen.
2000.
Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation.
J. Virol.
74:3105-3111[Abstract/Free Full Text].
|
| 38.
|
Young, D.,
P. A. Lawlor,
P. Leone,
M. Dragunow, and M. J. During.
1999.
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective.
Nat. Med.
5:448-453[CrossRef][Medline].
|
| 39.
|
Zufferey, R.,
D. Nagy,
R. J. Mandel,
L. Naldini, and D. Trono.
1997.
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.
Nat. Biotechnol.
15:871-875[CrossRef][Medline].
|
Journal of Virology, December 2000, p. 11278-11285, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Masson, C., Bury-Mone, S., Guiot, E., Saez-Cirion, A., Schoevaert-Brossault, D., Brachet-Ducos, C., Delelis, O., Subra, F., Jeanson-Leh, L., Mouscadet, J.-F.
(2007). Ku80 Participates in the Targeting of Retroviral Transgenes to the Chromatin of CHO Cells. J. Virol.
81: 7924-7932
[Abstract]
[Full Text]
-
Maxwell, P. H., Curcio, M. J.
(2007). Host Factors That Control Long Terminal Repeat Retrotransposons in Saccharomyces cerevisiae: Implications for Regulation of Mammalian Retroviruses. Eukaryot Cell
6: 1069-1080
[Full Text]
-
Yoder, K., Sarasin, A., Kraemer, K., McIlhatton, M., Bushman, F., Fishel, R.
(2006). The DNA repair genes XPB and XPD defend cells from retroviral infection. Proc. Natl. Acad. Sci. USA
103: 4622-4627
[Abstract]
[Full Text]
-
Lee, S.-H., Oshige, M., Durant, S. T., Rasila, K. K., Williamson, E. A., Ramsey, H., Kwan, L., Nickoloff, J. A., Hromas, R.
(2005). The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair. Proc. Natl. Acad. Sci. USA
102: 18075-18080
[Abstract]
[Full Text]
-
Ariumi, Y., Turelli, P., Masutani, M., Trono, D.
(2005). DNA Damage Sensors ATM, ATR, DNA-PKcs, and PARP-1 Are Dispensable for Human Immunodeficiency Virus Type 1 Integration. J. Virol.
79: 2973-2978
[Abstract]
[Full Text]
-
DeHart, J. L., Andersen, J. L., Zimmerman, E. S., Ardon, O., An, D. S., Blackett, J., Kim, B., Planelles, V.
(2005). The Ataxia Telangiectasia-Mutated and Rad3-Related Protein Is Dispensable for Retroviral Integration. J. Virol.
79: 1389-1396
[Abstract]
[Full Text]
-
Nielsen, A. A., Sorensen, A. B., Schmidt, J., Pedersen, F. S.
(2005). Analysis of Wild-Type and Mutant SL3-3 Murine Leukemia Virus Insertions in the c-myc Promoter during Lymphomagenesis Reveals Target Site Hot Spots, Virus-Dependent Patterns, and Frequent Error-Prone Gap Repair. J. Virol.
79: 67-78
[Abstract]
[Full Text]
-
Waninger, S., Kuhen, K., Hu, X., Chatterton, J. E., Wong-Staal, F., Tang, H.
(2004). Identification of Cellular Cofactors for Human Immunodeficiency Virus Replication via a Ribozyme-Based Genomics Approach. J. Virol.
78: 12829-12837
[Abstract]
[Full Text]
-
Daniel, R., Greger, J. G., Katz, R. A., Taganov, K. D., Wu, X., Kappes, J. C., Skalka, A. M.
(2004). Evidence that Stable Retroviral Transduction and Cell Survival following DNA Integration Depend on Components of the Nonhomologous End Joining Repair Pathway. J. Virol.
78: 8573-8581
[Abstract]
[Full Text]
-
Yant, S. R., Kay, M. A.
(2003). Nonhomologous-End-Joining Factors Regulate DNA Repair Fidelity during Sleeping Beauty Element Transposition in Mammalian Cells. Mol. Cell. Biol.
23: 8505-8518
[Abstract]
[Full Text]
-
Van Maele, B., De Rijck, J., De Clercq, E., Debyser, Z.
(2003). Impact of the Central Polypurine Tract on the Kinetics of Human Immunodeficiency Virus Type 1 Vector Transduction. J. Virol.
77: 4685-4694
[Abstract]
[Full Text]
-
Siva, A. C., Bushman, F.
(2002). Poly(ADP-Ribose) Polymerase 1 Is Not Strictly Required for Infection of Murine Cells by Retroviruses. J. Virol.
76: 11904-11910
[Abstract]
[Full Text]
-
Pluymers, W., Pais, G., Van Maele, B., Pannecouque, C., Fikkert, V., Burke, T. R. Jr., De Clercq, E., Witvrouw, M., Neamati, N., Debyser, Z.
(2002). Inhibition of Human Immunodeficiency Virus Type 1 Integration by Diketo Derivatives. Antimicrob. Agents Chemother.
46: 3292-3297
[Abstract]
[Full Text]
-
Jeanson, L., Mouscadet, J.-F.
(2002). Ku Represses the HIV-1 Transcription. IDENTIFICATION OF A PUTATIVE Ku BINDING SITE HOMOLOGOUS TO THE MOUSE MAMMARY TUMOR VIRUS NRE1 SEQUENCE IN THE HIV-1 LONG TERMINAL REPEAT. J. Biol. Chem.
277: 4918-4924
[Abstract]
[Full Text]
-
Ha, H. C., Juluri, K., Zhou, Y., Leung, S., Hermankova, M., Snyder, S. H.
(2001). Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration. Proc. Natl. Acad. Sci. USA
10.1073/pnas.051633498v1
[Abstract]
[Full Text]
-
Ha, H. C., Juluri, K., Zhou, Y., Leung, S., Hermankova, M., Snyder, S. H.
(2001). Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration. Proc. Natl. Acad. Sci. USA
98: 3364-3368
[Abstract]
[Full Text]